ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $605,000 | -60.9% | 49,000 | -53.9% | 0.05% | -62.2% |
Q4 2017 | $1,548,000 | -54.8% | 106,400 | -55.8% | 0.14% | -8.2% |
Q3 2017 | $3,426,000 | +167.7% | 240,800 | +140.1% | 0.15% | +30.1% |
Q2 2017 | $1,280,000 | +0.6% | 100,300 | 0.0% | 0.11% | -8.9% |
Q1 2017 | $1,272,000 | +18.3% | 100,300 | -4.7% | 0.12% | -1.6% |
Q4 2016 | $1,075,000 | -25.9% | 105,300 | -4.4% | 0.13% | -33.3% |
Q3 2016 | $1,451,000 | -1.5% | 110,200 | -5.0% | 0.19% | -12.1% |
Q2 2016 | $1,473,000 | -47.3% | 116,000 | -45.2% | 0.22% | -51.2% |
Q1 2016 | $2,796,000 | -15.7% | 211,680 | -1.9% | 0.44% | -19.7% |
Q4 2015 | $3,317,000 | +6.7% | 215,680 | -14.0% | 0.55% | +6.0% |
Q3 2015 | $3,108,000 | -9.4% | 250,680 | 0.0% | 0.52% | -3.0% |
Q2 2015 | $3,429,000 | +14.4% | 250,680 | 0.0% | 0.53% | +13.9% |
Q1 2015 | $2,998,000 | +11.4% | 250,680 | +19.0% | 0.47% | +2.6% |
Q4 2014 | $2,690,000 | +228.0% | 210,680 | +244.8% | 0.46% | +165.7% |
Q3 2014 | $820,000 | – | 61,110 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |